Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
After two years of dedicated and persistent advocacy by ADI, dementia will, for the first time, be formally recognised within the new UN Political Declaration on noncommunicable diseases (NCDs) and mental health, as a leading NCD.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
ADI hosts African regional member meeting The event brought together 17 ADI members and developing members across the African continent to discuss shared challenges, exchange ideas and foster solidarity and collaboration across the region.
On 10 December, ADI held its 2nd End of Year forecast event, focusing on the important topic of diagnosis under the theme of ‘The Diagnostics Revolution; Are We Ready’. Watch the recording and read ADI's highlights.
9 December, ADI CEO Paola Barbarino joined the 19th Rencontre France Alzheimer, hosted by France Alzheimer in Paris. This event convened representatives from across the country, as well as and Francophone countries, to discuss the latest developments in dementia treatment, diagnostics, care and support.
As we approach the end of the calendar year, ADI CEO Paola Barbarino shares her end-of-year message with our members, friends and colleagues, reflecting on our work in 2025 and offering a preview of what 2026 will bring.
November 2025 saw a plethora of activity across the European region. From engagements in Ibiza, Reykjavík and Manchester, UK. ADI took part in key events with its members throughout the region to promote greater awareness and activity, towards addressing the growing burden of dementia.
From 17 to 21 November, ADI CEO Paola Barbarino joined Regional Director for the Asia Pacific, DY Suharya and Head of Accreditation Amalia Fonk-Utomo in Hong Kong SAR and Macau SAR for a week of important meetings, regional activities, and the ADI APRO Members Regional Conference.
ADI welcomes the approval of Peru’s National Plan for the Prevention and Treatment of Alzheimer’s Disease and Other Dementias 2026–2028, officially validated by the Ministry of Health through a newly published ministerial resolution. This landmark decision places dementia firmly on Peru’s national health agenda and opens the door to implementation after years of dedicated advocacy from civil society, academia, and key partners.
From Switzerland to Italy, ADI has taken part in key engagements on the European continent that convened industry leaders, clinicians, specialists, researchers, regulators, policymakers, advocates, people living with dementia and their carers to bring new insights and strategies to light.